<DOC>
	<DOCNO>NCT01801774</DOCNO>
	<brief_summary>Phacoemulsification quick method less complication cataract surgery . Due use ultrasonic energy , produce post-operative inflammation method . Many route steroid use control post-operative inflammation . The investigator compare efficacy single depot steroid subtenon injection ( 20-mg triamcinolone ) four-time-a-day steroid eye drop ( 0.1 % dexamethasone ) control inflammation uneventful phacoemulsification .</brief_summary>
	<brief_title>Efficacy Comparison Study Steroids Control Post-operative Inflammation</brief_title>
	<detailed_description>Cataract one common cause blindness world . Surgical removal lens treatment cataract , shift extracapsular cataract extraction phacoemulsification . Although phacoemulsification provide faster operate time give well optical result rapid recovery patient , cause inflammation post-operatively compare extracapsular cataract extraction . Corticosteroids eye drop mainly use control intraocular inflammation surgery . Other route corticosteroid introduce increase intraocular level increase patient 's compliance . Subtenon triamcinolone injection easy safe . Antiinflammatory effect single subtenon triamcinolone injection last 4-6 week . This method use combination corticosteroid eye drop control inflammation cataract surgery uveitic patient . It show potency control intraocular inflammation lower rate increase intraocular pressure . The investigator quantitatively compare efficacy subtenon 20-mg triamcinolone injection 0.1 % dexamethasone eye drop control intraocular inflammation uneventful phacoemulsification .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Age old 18 year old Uncomplicated cataract patient schedule phacoemulsification posterior chamber intraocular lens implantation No History prior intraocular procedure eye diseases uveitis , glaucoma , diabetic retinopathy No History systemic autoimmune diseases No History allergy corticosteroid component study medication No History use corticosteroid , nonsteroidal antiinflammatory drug ( NSAIDs ) , immunomodulating agent within 3 month prior surgery Complications occur cataract surgery rupture posterior capsule , vitreous loss , drop nucleus Pregnant lactating woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>post-operative inflammation</keyword>
	<keyword>steroid</keyword>
	<keyword>intraocular pressure</keyword>
</DOC>